Cargando…

Cyclin G2 Suppresses Glomerulosclerosis by Regulating Canonical Wnt Signalling

Recent data has shown that cyclin G2 (CCNG2) is an atypical cyclin that inhibits cell cycle progression and is often dysregulated in human cancers. The involvement of cyclin G2 in the occurrence and development of diabetic nephropathy (DN) has not been determined. In the present study, we conducted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Chenyang, Gao, Jinlan, Li, Sen, Liu, Qi, Hou, Xiaoyu, Liu, Shenghuan, Xing, Xuesha, Sun, Manni, Wang, Shusen, Luo, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215590/ https://www.ncbi.nlm.nih.gov/pubmed/30420966 http://dx.doi.org/10.1155/2018/6938482

Ejemplares similares

Corrigendum to “Cyclin G2 Suppresses Glomerulosclerosis by Regulating Canonical Wnt Signalling”
por: Zhao, Chenyang, et al.
Publicado: (2019)

Cyclin G2 regulates canonical Wnt signalling via interaction with Dapper1 to attenuate tubulointerstitial fibrosis in diabetic nephropathy
por: Zhao, Chenyang, et al.
Publicado: (2020)

Cyclin G2 suppresses Wnt/β-catenin signaling and inhibits gastric cancer cell growth and migration through Dapper1
por: Gao, Jinlan, et al.
Publicado: (2018)

Cyclin G2 Is Involved in the Proliferation of Placental Trophoblast Cells and Their Interactions with Endothelial Cells
por: Sun, Manni, et al.
Publicado: (2020)

Cyclin G2 Inhibits the Warburg Effect and Tumour Progression by Suppressing LDHA Phosphorylation in Glioma
por: Li, Sen, et al.
Publicado: (2019)

Cyclin G2 reverses immunosuppressive tumor microenvironment and potentiates PD-1 blockade in glioma
por: Li, Sen, et al.
Publicado: (2021)

Cyclin G2 Suppresses Estrogen-Mediated Osteogenesis through Inhibition of Wnt/β-Catenin Signaling
por: Gao, Jinlan, et al.
Publicado: (2014)

Cyclin G2 in macrophages triggers CTL-mediated antitumor immunity and antiangiogenesis via interferon-gamma
por: Liu, Lu, et al.
Publicado: (2022)

Cyclin G2 Inhibits Oral Squamous Cell Carcinoma Growth and Metastasis by Binding to IGFBP3 and Regulating the FAK-SRC-STAT Signaling Pathway
por: Wang, Danning, et al.
Publicado: (2020)

Overexpression of DOC-1R Inhibits Cell Cycle G1/S Transition by Repressing CDK2 Expression and Activation
por: Liu, Qi, et al.
Publicado: (2013)

Cholesterol selectively activates canonical Wnt signalling over non-canonical Wnt signalling
por: Sheng, Ren, et al.
Publicado: (2014)

Multiple suppression pathways of canonical Wnt signalling control thymic epithelial senescence
por: Varecza, Zoltan, et al.
Publicado: (2011)

Inhibition of phosphodiesterase 5 reduces bone mass by suppression of canonical Wnt signaling
por: Gong, Y, et al.
Publicado: (2014)

Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/β-catenin signaling
por: Bernaudo, S, et al.
Publicado: (2016)

Colorectal cancer cells suppress CD4+ T cells immunity through canonical Wnt signaling
por: Sun, Xuan, et al.
Publicado: (2017)

Wnt Signaling Upregulates Teneurin-3 Expression via Canonical and Non-canonical Wnt Pathway Crosstalk
por: Bastías-Candia, Sussy, et al.
Publicado: (2019)

Dose-Dependent Effect of Estrogen Suppresses the Osteo-Adipogenic Transdifferentiation of Osteoblasts via Canonical Wnt Signaling Pathway
por: Gao, Bo, et al.
Publicado: (2014)

Antiangiogenic and Antineuroinflammatory Effects of Kallistatin Through Interactions With the Canonical Wnt Pathway
por: Liu, Xiaochen, et al.
Publicado: (2013)

Quercetin suppresses glomerulosclerosis and TGF-β signaling in a rat model
por: Liu, Yifan, et al.
Publicado: (2019)

Pirfenidone suppressed the development of glomerulosclerosis in the FGS/Kist mouse.
por: Park, Ho-Sun, et al.
Publicado: (2003)

Lovastatin Inhibits RhoA to Suppress Canonical Wnt/β-Catenin Signaling and Alternative Wnt-YAP/TAZ Signaling in Colon Cancer
por: Xiao, Yi, et al.
Publicado: (2022)

Discrete roles of canonical and non-canonical Wnt signaling in hematopoiesis and lymphopoiesis
por: Famili, F, et al.
Publicado: (2015)

Erratum: Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/β-catenin signalling
por: Bernaudo, S, et al.
Publicado: (2016)

KCTD1 Suppresses Canonical Wnt Signaling Pathway by Enhancing β-catenin Degradation
por: Li, Xinxin, et al.
Publicado: (2014)

THE CANONICAL WNT PATHWAY IN GASTRIC CARCINOMA
por: de OLIVEIRA, Levindo Alves, et al.
Publicado: (2019)

The structural biology of canonical Wnt signalling
por: Agostino, Mark, et al.
Publicado: (2020)

Wnt Glycation Inhibits Canonical Signaling
por: Ye, Zhennan, et al.
Publicado: (2019)

217 Is it Idiopathic Nodular Glomerulosclerosis or Diabetic Glomerulosclerosis?
Publicado: (2022)

Research progress in the radioprotective effect of the canonical Wnt pathway
por: Wang, Jin-Feng, et al.
Publicado: (2013)

The interaction of canonical Wnt/β-catenin signaling with protein lysine acetylation
por: You, Hongjuan, et al.
Publicado: (2022)

Canonical Wnt Signaling Pathway on Polarity Formation of Utricle Hair Cells
por: Deng, Di, et al.
Publicado: (2021)

Canonical WNT Signaling Activated by WNT7B Contributes to L-HBs-Mediated Sorafenib Resistance in Hepatocellular Carcinoma by Inhibiting Mitophagy
por: Liu, Li-Juan, et al.
Publicado: (2022)

Noncanonical Wnt5a Signaling Suppresses Hippo/TAZ-Mediated Osteogenesis Partly Through the Canonical Wnt Pathway in SCAPs
por: Fu, Yajing, et al.
Publicado: (2022)

Agonistic and Antagonistic Roles for TNIK and MINK in Non-Canonical and Canonical Wnt Signalling
por: Mikryukov, Alexander, et al.
Publicado: (2012)

Components of the Canonical and Non-Canonical Wnt Pathways Are Not Mis-Expressed in Pituitary Tumors
por: Colli, Leandro Machado, et al.
Publicado: (2013)

Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases
por: Ackers, Ian, et al.
Publicado: (2017)

Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway
por: Xu, Weiru, et al.
Publicado: (2011)

Surrogate Wnt agonists that phenocopy canonical Wnt/β-catenin signaling
por: Janda, Claudia Y., et al.
Publicado: (2017)

Retraction: KCTD1 Suppresses Canonical Wnt Signaling Pathway by Enhancing β-catenin Degradation
Publicado: (2022)

SPARCL1 suppresses osteosarcoma metastasis and recruits macrophages by activation of canonical WNT/β-catenin signaling through stabilization of the WNT–receptor complex
por: Zhao, S-J, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ku0ovb7jfonvie3pbf7b23je7p